Philip Hewitt

Philip Hewitt

Company: Merck Healthcare KGaA

Job title: Global Head of Early Investigative Toxicology

Seminars:

Chairs Closing Remarks & End of Summit 4:45 pm

Read more

day: Day Two

Chair’s Opening Remarks 8:50 am

Read more

day: Day Two

Should we be Utilizing or Moving Away from Animal Models? 5:00 pm

Hear industry leaders discuss the topic of the use of animal models with 3D tissue models. Can we show that these 3D models really do predict and reflect what is happening in vivo in relation to the patient? Should we be using this to move away from animal models or use in conjunction with? Discuss…Read more

day: Day One

Advanced Intestinal Models for Preclinical Safety: Validation of An Organ-on-a-chip System for Early Screening 2:00 pm

Comparison of 2D, 3D and OOAC cell models: which context of use is each fit for Assessment of iPSC derived colon organoids Pre-validation and implementation of OOAC small intestine model (CaCo2) Future perspectives and more complex intestinal modelsRead more

day: Track B - Day 1 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.